OFFLINE

BERGER PAINTS
==========

FUNDAMENTAL DATA:
=================


CATEGORY:     DA
FV:     10.00
ML:     50
NAV:     57.25
EPS:     32.67
EPS(2009):     25.00
EPS GROWTH:     30.68
NPAT:     757.52
NPAT(2009):     579.68
NPAT GROWTH:     30.68
LAST TRADE PRICE(27-01-2-11):     801.70
P/E:     24.54
PRICE/NAV:     14.00
ROE:     57.07
AUTHORISED CAPITAL:     400.00
PAID UP CAPITAL:     231.89
PUBLIC CAPITAL:     3.94
LDIV:YEND:     150% : 1209
RTAG:     Q3

Comment:
Fundamental Strength:MEDIUM



TECHNICAL ANALYSIS:
==============




Price and moving averages:
BERGERPBL has closed above its Short time moving average.
Short time moving average is currently below mid-time, AND below long time moving averages.
The relationship between price and moving averages is: neutral in short-term, and neutral in mid-long term.

Bollinger Bands:
BERGERPBL has closed below upper band by 29.1%.
Bollinger Bands are 61.8% narrower than normal.
The narrow width of the bands suggests low volatility as compared to BERGERPBL()'s normal range.  Therefore, the probability of volatility increasing with a sharp price move has increased for the near-term. The bands have been in this narrow range for 29 bars. The probability of a significant price move increases the longer the bands remain in this narrow range.

RSI
The current value for the RSI15 is   50.636
The RSI is not currently in a topping (above 70) or bottoming (below 30) range.
Failure Swings (also known as support or resistance penetrations or breakouts):The RSI has just reached its highest value in the last 14 period(s).  This is bullish.
Divergence:
The RSI has set a new 14-day high while the security price has not.  This is a bullish divergence.


MACD
MACD Value:  -24.222, Signal Line:  -27.881
Crossovers:
Currently the MACD is bullish since it is trading above its signal line.
The MACD crossed above its signal line 0 period(s) ago.
Overbought/Oversold:
The MACD is not in an Overbought/Oversold range.
Divergence:
There have been no divergence signals within the last 5 periods.

CAUTION:This commentary is not a recommendation to buy or sell. Use at your own risk.